e-learning
resources
London 2016
Monday, 05.09.2016
Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study
Laurent Morin (Saint Priest Cedex, France), Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Patrick Levy, Frédéric Goutorbe, Laurent Morin, Jean-Louis Pepin, Marie-Pia d’Ortho
Source:
International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Session:
Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Session type:
Thematic Poster
Number:
2373
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laurent Morin (Saint Priest Cedex, France), Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Patrick Levy, Frédéric Goutorbe, Laurent Morin, Jean-Louis Pepin, Marie-Pia d’Ortho. LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study. Eur Respir J 2016; 48: Suppl. 60, 2373
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
LATE-BREAKING ABSTRACT: Heart rate variability (HRV) in patients with severe obstructive sleep apnea syndrome (OSA) and its response to a 3-month continuous positive airway pressure (CPAP) therapy
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV)
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV).
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019
FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results.
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020
Late Breaking Abstract - FACE: Prospective multicenter cohort adressing chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV): patient baseline characteristics
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
LATE-BREAKING ABSTRACT: Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results
Source: International Congress 2015 – Latest developments in clinical studies in acute and chronic lung diseases
Year: 2015
Reliability of the apnoea-hypopnoea index (AHI) reported by ventilator software in patients with obesity hypoventilation syndrome (OHS) treated with long-term noninvasive ventilation (NIV)
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Does obstructive lung disease impact the survival of patients with obesity-related respiratory failure treated with nocturnal NIV?
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up
Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters?
Year: 2015
LATE-BREAKING ABSTRACT: ORCADES: a prospective cohort study of severe obstructive sleep apnoea (OSA) patients receiving second line-treatment with a mandibular repositioning device (MRD)
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
LATE-BREAKING ABSTRACT: 2-years follow-up (FU) results of ORCADES study: Long-term mandibular repositioning device (MRD) therapy in patients treated for obstructive sleep apnea (OSA)
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
CPAP to treat obstructive sleep apnoea (OSA) in children with Down syndrome (DS)
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Long-term efficacy of adaptive servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-stokes respiration (CSR). A randomised CPAP-controlled trial
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009
Nocturnal oxygen therapy (NOT)
versus
nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years
Source: Eur Respir J 2002; 20: Suppl. 38, 9s
Year: 2002
Predictors of mortality for patients with obesity-related respiratory failure treated with nocturnal non-invasive ventilation
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept